Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Cipla Limited patents


Recent patent applications related to Cipla Limited. Cipla Limited is listed as an Agent/Assignee. Note: Cipla Limited may have other listings under different names/spellings. We're not affiliated with Cipla Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cipla Limited-related inventors


Stabilized liquid fosaprepitant formulations

The present invention relates to stable pharmaceutical compositions of fosaprepitant or a salt thereof in the form of ready-to-use or ready-to-dilute compositions suitable for parenteral administration.. . ... Cipla Limited

Stable carfilzomib formulations

Disclosed herein are stabilized formulations of carfilzomib. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.. ... Cipla Limited

Stabilized cabazitaxel formulations

Disclosed herein are improved formulations for the cabazitaxel. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.. ... Cipla Limited

Mesalamine for the treatment of cancer

Methods of treating renal cancer, including renal cell carcinoma, using mesalamine are disclosed herein. Mesalamine can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.. ... Cipla Limited

Method of treatment of hepatitis c

The present invention relates to pharmaceutical composition of calcium channel blocker for the method of treatment of hepatitis c in humans. The methods of the present invention can be used in patients with hepatitis c administering calcium channel blocker such as isradipine, optionally in combination with one or more anti-hepatitis c drugs.. ... Cipla Limited

Stabilized cabazitaxel formulations

Disclosed herein are improved formulations for the cabazitaxel. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.. ... Cipla Limited

Methods for making serotonin reuptake inhibitors

The present invention relates to a process for preparing serotonin reuptake inhibitors of formula (i) and pharmaceutically acceptable salts thereof, (formula (i)) wherein, r1, r2, r3, l, m, n and z are as defined in the specification.. . ... Cipla Limited

Method of treating hypertension

Disclosed herein are compositions and methods for the treatment of pulmonary hypertension, including pulmonary arterial hypertension. The methods include administering to a patient in need thereof an effective amount of cinitapride or derivative thereof. ... Cipla Limited

Methazolamide for the treatment of cancer

The present invention relates to methods of using methazolamide to treat pancreatic cancer. Pancreatic cancer can be treated by administering to a patient in need thereof an effective amount of methazolamide, optionally in combination with one or more additional cancer therapies.. ... Cipla Limited

Ketorolac for the treatment of cancer

Methods of treating cancer, including par-4 implicated cancers or renal cell carcinoma, using ketorolac are disclosed herein. Ketorolac can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.. ... Cipla Limited

Bezafibrate for the treatment of cancer

Methods of treating renal cancer, including renal cell carcinoma, using bezafibrate are disclosed herein. Bezafibrate can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.. ... Cipla Limited

Mesalamine for the treatment of cancer

Methods of treating renal cancer, including renal cell carcinoma, using mesalamine are disclosed herein. Mesalamine can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.. ... Cipla Limited

Par-4 agonists for the treatment of cancer

Disclosed herein are methods of treating cancers by administration of a par-4 agonist.. . ... Cipla Limited

Polymorphic forms of methyl((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl)carbamate and salts thereof

Amorphous methyl((1s)-1-(((2s)-2-(5-(4′-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl) carbamate free base, amorphous methyl((1s)-1-(((2s)-2-(5-(4′-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl) carbamate dihydrochloride, methods of making them, and pharmaceutical compositions containing them.. . ... Cipla Limited

12/07/17 / #20170348259

Treatment of hepatitis c using histone deacetylase inhibitors

The present invention relates to method of treatment of hepatitis c using bufexamac or a derivative thereof. The methods of the present invention can be used in patients with hepatitis c administering bufexamac or a derivative thereof in combination with one or more anti-hepatitis c drugs.. ... Cipla Limited

11/23/17 / #20170333452

Pharmaceutical compositions

A pharmaceutical composition for inhalation comprising r (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.. . ... Cipla Limited

11/16/17 / #20170326102

Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery

The present invention relates to pharmaceutical composition for intranasal or pulmonary delivery, wherein the composition comprises an artemisinin derivative and optionally one or more pharmaceutically acceptable excipients. The pharmaceutical composition may be for intranasal delivery, may be in the form of a nasal spray, a solution, a suspension, nasal drops, an insufflation powder or a nasal powder, and may be suitable for delivery using a nebulizer, insufflator, powder sprayer or powder inhaler. ... Cipla Limited

09/21/17 / #20170267669

Process for the preparation of rivaroxaban

The present invention relates to an environmentally friendly process for preparing rivaroxaban. The present invention provides a process for preparing rivaroxaban of formula i, the process comprising: reacting a compound of formula vi with a base in the presence of a solvent to form a compound of formula vii; and condensing the compound of formula vii with a compound of formula viii or a compound of formula ix in the presence of a solvent to prepare rivaroxaban of formula i, wherein the solvent used in both steps comprises water.. ... Cipla Limited

08/24/17 / #20170240561

Process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof

The present invention discloses a novel process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts thereof and to novel intermediates which are produced during the course of carrying out the novel process.. . ... Cipla Limited

08/17/17 / #20170232020

Pharmaceutical compositions

An oral or injectable pharmaceutical composition is provided for treating diseases caused by retroviruses or hepatitis b viruses. The composition comprises a therapeutically effective amount of at least one anti-retroviral drug and a therapeutically effective amount of at least one pharmacokinetic booster or enhancer or derivative thereof. ... Cipla Limited

08/03/17 / #20170217988

Process for the synthesis of everolimus and intermediates thereof

The present invention relates to a novel process for the synthesis of everolimus of formula (i): and intermediates thereof.. . ... Cipla Limited

07/20/17 / #20170202794

Treatment of hepatitis c using histone deacetylase inhibitors

The present invention relates to method of treatment of hepatitis c using bufexamac or a derivative thereof. The methods of the present invention can be used in patients with hepatitis c administering bufexamac or a derivative thereof in combination with one or more anti-hepatitis c drugs.. ... Cipla Limited

06/29/17 / #20170181988

Methods for the treatment of bladder cancer

Methods of treating bladder cancer using adapalene are disclosed herein. Adapalene can be administered as part of a comprehensive treatment program, which can also include chemotherapy, immunotherapy, radiation therapy and/or surgical treatment.. ... Cipla Limited

06/22/17 / #20170173052

Methods of treating ovarian cancer

Disclosed herein are methods of treating ovarian cancer comprising administering to a subject in need thereof an effective amount of methacycline, or a pharmaceutically acceptable salt thereof. The methacycline can be administered as part of treatment regimen, which also can include other chemo- or immune-therapies, radiation therapy, and/or surgical treatments.. ... Cipla Limited

06/15/17 / #20170165257

Method for the treatment of bladder cancer

Methods of treating bladder cancer using terconazole are disclosed herein. Terconazole can be administered as part of a comprehensive treatment program, which can also include chemotherapy, immunotherapy, radiation therapy and/or surgical treatment.. ... Cipla Limited

06/08/17 / #20170157125

Method of treating hypertension

Disclosed herein are compositions and methods for the treatment of pulmonary hypertension, including pulmonary arterial hypertension. The methods include administering to a patient in need thereof an effective amount of anagrelide or derivative thereof. ... Cipla Limited

06/08/17 / #20170157064

Methods for the treatment of hepatitis c

The present invention relates to method of treatment of hepatitis c using hexestrol or a derivative thereof. The methods of the present invention can be used in patients with hepatitis c administering hexestrol or a derivative thereof in combination with one or more anti-hepatitis c drugs.. ... Cipla Limited

05/04/17 / #20170119744

Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent

The present invention relates to pharmaceutical compositions for inhalation which comprise one or more bronchodilators.. . ... Cipla Limited

04/06/17 / #20170095453

Low dose pharmaceutical composition

This invention provides a low dose pharmaceutical composition comprising deferasirox or a pharmaceutically acceptable derivative thereof and one or more pharmaceutically acceptable excipients. A unit dose of the pharmaceutical composition comprises from about 50 mg to about 100 mg of deferasirox, from about 150 mg to about 200 mg of deferasirox or from about 260 mg to about 350 mg of deferasirox. ... Cipla Limited

02/09/17 / #20170035780

Combination of azelastine and fluticasone for nasal administration

A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.. . ... Cipla Limited

02/02/17 / #20170027908

Pharmaceutical composition

Described herein are pharmaceutical compositions for inhalation comprising glycopyrrolate, a beta2-agonist, and optionally an inhaled corticosteroid; to a process for preparing such compositions and to the use of such compositions for the prevention and/or treatment of respiratory, inflammatory or obstructive airway disease.. . ... Cipla Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cipla Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cipla Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###